Actively Recruiting

Phase 4
Age: 0 - 9Years
All Genders
NCT06624631

PDMC Implementation Trial in Kenya

Led by Liverpool School of Tropical Medicine · Updated on 2025-11-21

600

Participants Needed

1

Research Sites

55 weeks

Total Duration

On this page

Sponsors

L

Liverpool School of Tropical Medicine

Lead Sponsor

K

Kenya Medical Research Institute

Collaborating Sponsor

AI-Summary

What this Trial Is About

The goal of this implementation trial is to evaluate at least two alternative delivery strategies and adherence support for malaria chemoprevention with dihydroartemisinin-piperaquine in the post-discharge management of children hospitalised with severe anaemia or severe malaria to optimise adherence in Kenya. The actual interventions to be evaluated have been co-designed with national stakeholders during an initial formative research stage.

CONDITIONS

Official Title

PDMC Implementation Trial in Kenya

Who Can Participate

Age: 0 - 9Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Health facilities with blood transfusion services offering in-patient care for children with severe anaemia and severe malaria
  • At least 40 children admitted per year with severe anaemia or severe malaria
  • Agreement to participate by facility management
  • Located in areas with moderate to high malaria transmission
  • Children younger than 10 years of both sexes
  • Hospitalised with severe anaemia (haemoglobin <5.0 g/dL or PCV <15%, or requiring blood transfusion) or severe malaria (requiring parenteral artesunate and/or confirmed Plasmodium infection)
Not Eligible

You will not qualify if you...

  • Health facilities without subservient lower-level health facilities
  • Recognised other causes of severe anaemia such as trauma, haematological malignancy, or known bleeding disorders like haemophilia
  • Sickle cell anaemia or sickle cell disease
  • Body weight less than 5 kg

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Kemri, Cghr

Kisumu, Kenya, 40 100

Actively Recruiting

Loading map...

Research Team

J

Jenny Hill, MSc, PhD

CONTACT

J

Juliet Otieno, MD, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

PREVENTION

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

PDMC Implementation Trial in Kenya | DecenTrialz